GenVivo to Present Pipeline Programs at the 2024 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
A new non-integrating retrovector for systemic gene delivery for multiple applications and pseudotyped retrovectors targeting specific tumor types in vivo SAN MARINO, CA, UNITED STATES, May 8, 2024 /EINPresswire.com/ -- GenVivo, Inc. (GVO) a …